Cut through the noise, find the signal: Intelligence for serious healthcare leaders
Analysis updated November 9, 2026
The IBH Model represents a structurally distinct bet within CMMI's portfolio: instead of bending behavioral health into primary care's orbit — the ACO/MSSP logic — CMS is inverting the hierarchy and making specialty BH the hub of whole-person care. This is not incremental. It is an architectural challenge to the long-dominant "primary care as quarterback" paradigm.
The two-cohort rollout is functionally the most important structural detail. Cohort 1 (Michigan, New York, South Carolina) launched January 1, 2025, with a 2025–2032 performance window. Cohort 2, governed by NOFO CMS-2Q2-26-001 posted October 16, 2025, will award up to five additional states at up to $7.5M each (total ceiling: $37.5M), with a two-year Pre-Implementation Period (January 2027–December 2028) and a five-year Implementation Period (January 2029–December 2033). Applications were due June 3, 2026; awards anticipated September 15, 2026. CMS has deliberately capped total state participation at eight across both cohorts — a constraint that signals evaluation rigor over scale.
The model's three-tier payment architecture reveals CMS's theory of change:
The Medicare-only participation prohibition is a critical design guardrail: practices cannot access ISP dollars unless they first participate in the state Medicaid payment arrangement. This forces multi-payer commitment and prevents cream-skimming of the Medicare revenue stream. The LAN category progression requirement (2A at baseline → 2B by MY3 → 2C or above for select measures by MY4) gives CMS a defensible scaffolding for evaluating payment maturation without mandating full capitation — a politically viable middle path under the current administration's preference for provider flexibility.
The requirement that Medicaid Payment Approaches come from existing state Medicaid funds (cooperative agreement dollars cannot count as FFP) is a hidden fiscal discipline mechanism. States must commit real Medicaid spending authority, not just federal pass-through, ensuring skin in the game.
For Practice Participants (assuming Medicare + Medicaid participation):
At the disclosed ISP range of $200–$220 PMPM, a practice with 200 attributed Medicare/dual-eligible beneficiaries generates $480,000–$528,000 annually in integration support revenue alone — before any performance bonuses and entirely separate from existing BH FFS collections. The minimum threshold is 25 Medicaid MSBH beneficiaries per month for eligibility; CMS anticipates roughly 10,000 Medicaid MSBH beneficiaries per state across the model, implying the practice-level scale needed for economic sustainability is achievable in moderately-sized community mental health operations.
Infrastructure funding up to $200,000 (Medicare/Medicaid dual participants) over the pre-implementation period represents meaningful startup capital for EHR upgrades, interoperability infrastructure, and care team staffing. A realistic build-out for a 5-FTE integrated care team (care manager, physical health consultant, peer support specialist, data coordinator, and a half-time medical director equivalent) in a mid-market labor environment runs $450,000–$600,000 annually. The ISP revenue at 200+ attributed members partially offsets this, but practices with fewer than 150 attributed Medicare beneficiaries will face negative cash flow on the care management investment unless Medicaid PMPM payments from states are substantial.
Break-even calculus: At $210 PMPM ISP and a $500,000 annual care team cost, a practice needs approximately 200 attributed Medicare/dual beneficiaries to cover team costs from ISP alone. Below that threshold, the model is subsidy-dependent until Medicaid alignment payments are factored in. Practices currently serving 300+ MSBH Medicaid beneficiaries monthly — common in CCBHCs and community mental health centers — have a credible path to surplus if they achieve Medicare participation.
Cash flow risk: The ISP is prospective (favorable), but performance-based payment reconciliation timing across a multi-year model introduces working capital uncertainty. Practices should model a 6–12 month receivables gap for PBP components in early implementation years.
Structurally advantaged:
Structurally disadvantaged:
Market consolidation signal: The model's infrastructure investment requirements ($100K–$200K per practice), multi-payer reporting demands, and quality measure obligations create a genuine barrier for standalone small practices. Expect state recipients to prioritize larger aggregators — CMHCs, CCBHC networks, health system-affiliated BH practices — in their recruitment strategies, accelerating BH market consolidation in participating states.
MSSP/ACO interaction: The NOFO prohibits duplicative billing codes but does not explicitly bar beneficiary overlap with MSSP-attributed populations. Dual-attributed Medicare beneficiaries represent a coordination complexity: ACO care managers and IBH care managers may generate conflicting care plans. Practices and ACOs in participating states need explicit attribution reconciliation protocols before implementation period launch.
Physician perspective: BH physicians (psychiatrists, addiction medicine physicians) stand to benefit most directly — the ISP and infrastructure funding arrive without the downside risk structure of shared savings models. There is no clawback mechanism described in source documents. The physical health consultant role creates a new revenue pathway for primary care and internal medicine physicians willing to contract with BH practices, though billing code clarity for the consultative (non-direct-treatment) role remains an acknowledged gap that CMS has committed to address.
Health system perspective: Health systems with affiliated BH practices in Cohort 1 or prospective Cohort 2 states face a strategic choice: position their BH subsidiaries as Practice Participants to capture ISP revenue, or risk ceding BH patient relationships to independent CMHC/CCBHC competitors who move faster. The three-year pre-implementation period offers a planning runway, but health systems accustomed to ACO/MSSP structures will need to build new BH-specific care management workflows rather than adapting existing primary care models. Systems with joint BH-PH operations (e.g., integrated delivery networks with owned psychiatric practices) have the strongest structural position.
Hospital perspective: Inpatient and post-acute settings are explicitly excluded from Practice Participant eligibility. Hospitals benefit indirectly if the model succeeds in reducing BH-related ED utilization and preventable hospitalizations — but they receive no direct payment. Hospitals with outpatient BH clinics operating at the outpatient level of care may qualify as Practice Participants through their clinic structures; this pathway deserves dedicated legal review, as eligibility hinges on the outpatient clinic meeting state licensing and Medicaid enrollment requirements independent of the hospital parent.
Payer/MA plan perspective: The model's explicit exclusion of MA beneficiaries from the Medicare Payment Approach is a significant limitation for plans with large dual-eligible populations in participating states. However, CMS has explicitly invited commercial payers — including MA plans — to voluntarily align with the IBH payment and care delivery framework through the convening structure. Plans that proactively align stand to benefit from network-level care integration improvements without bearing the administrative cost of model participation. Plans that ignore IBH risk provider network fragmentation as Practice Participants optimize workflows for FFS Medicare and Medicaid attributed populations at the expense of MA member management.
VE Bottom Line: IBH is the most structurally coherent BH payment innovation CMMI has fielded — its multi-payer alignment requirements, prospective ISP payment, and mandatory progression away from FFS are genuinely differentiated from prior BH demonstrations. The model favors organizations with existing Medicaid scale, BH/PH integration infrastructure, and tolerance for a three-year investment runway before implementation-period revenue materializes. Prospective Cohort 2 state applicants should treat the June 2026 deadline as their last practical entry point into a model that, if successful, has explicit scale-and-spread authority under Section 1115A.